[Iatrogenic ergotism. Responsibility of an ergotamine tartrate-erythromycine propionate association (author's transl)].
Acute ischemia of the lower limbs was seen in a patient given ergotamine tartrate with erythromycine propionate. The authors recall the danger of such associations in patients with hepatic failure, the value of early diagnosis, and the possible use of nitroglycerin for suppressing the vascular spasm.
D000328:Adult; D004359:Drug Therapy, Combination; D004878:Ergotamine; D004879:Ergotamines / Q000009:adverse effects*; D004881:Ergotism / Q000209:etiology*; D004917:Erythromycin / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007511:Ischemia / Q000139:chemically induced* / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male
D004879:Ergotamines; D004917:Erythromycin; C011807:erythromycin propionate; D004878:Ergotamine
Ergotisme iatrogène: rôle de l'association tartrate d'erogtamine- propionate d'érythromycine.